QS Investors, LLC - EXELIXIS INC ownership

EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 343 filers reported holding EXELIXIS INC in Q3 2019. The put-call ratio across all filers is 0.48 and the average weighting 0.3%.

Quarter-by-quarter ownership
QS Investors, LLC ownership history of EXELIXIS INC
ValueSharesWeighting
Q2 2020$198,000
+37.5%
8,3230.0%0.00%
+50.0%
Q1 2020$144,000
-2.0%
8,3230.0%0.00%
+100.0%
Q4 2019$147,000
-0.7%
8,3230.0%0.00%
-50.0%
Q3 2019$148,000
-93.6%
8,323
-92.3%
0.00%
-92.0%
Q2 2019$2,304,000
-0.4%
107,770
+10.9%
0.02%0.0%
Q1 2019$2,313,000
+84.3%
97,152
+52.3%
0.02%
+56.2%
Q4 2018$1,255,000
-48.0%
63,790
-53.1%
0.02%
-30.4%
Q3 2018$2,412,000
-21.2%
136,145
-4.3%
0.02%
-23.3%
Q2 2018$3,062,000
-2.9%
142,3040.0%0.03%
-6.2%
Q1 2018$3,152,000
+567.8%
142,304
+815.7%
0.03%
+700.0%
Q4 2017$472,000
+25.2%
15,5400.0%0.00%
+33.3%
Q3 2017$377,000
-1.6%
15,5400.0%0.00%0.0%
Q2 2017$383,000
+122.7%
15,540
+95.8%
0.00%
+200.0%
Q1 2017$172,000
+17100.0%
7,938
+20789.5%
0.00%
Q4 2016$1,0000.0%38
+11.8%
0.00%
Q2 2016$1,0000.0%34
-32.0%
0.00%
Q4 2015$1,000500.00%
Other shareholders
EXELIXIS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Meditor Group Ltd 15,966,038$282,918,00060.81%
NEXTHERA CAPITAL LP 1,735,030$30,745,0005.89%
GREAT POINT PARTNERS LLC 2,075,000$36,769,0005.73%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 704,534$9,574,0004.55%
Matrix Capital Management Company, LP 10,000,000$177,200,0004.38%
Consonance Capital Management LP 3,879,050$68,737,0003.70%
Rhenman & Partners Asset Management AB 1,261,414$22,352,0002.24%
BB BIOTECH AG 2,785,000$49,350,0001.31%
CAPITAL MANAGEMENT CORP /VA 285,575$5,060,0001.29%
TEALWOOD ASSET MANAGEMENT INC 155,376$2,753,0001.03%
View complete list of EXELIXIS INC shareholders